Skip to content
Screener

Prime Medicine PRME Interest Income

Interest Income at other companies

Intellia Therapeutics logo
Intellia TherapeuticsNTLA
$5.8M-21.7%
Regenxbio logo
RegenxbioRGNX
$1.22M-63.8%
Sarepta Therapeutics, Inc. logo
Sarepta Therapeutics, Inc.SRPT
$6.21M+18.1%
MeiraGTx Holdings plc logo
MeiraGTx Holdings plcMGTX
$189K-80.5%
Wave Life Sciences logo
Wave Life SciencesWVE
$4.72M+99.1%

Other financials

Income statement

See full
Revenue$838.0K-61.6%
Operating income-$43.3M+18.9%
Net income-$42.1M+19.9%
EPS (diluted)-$0.24+41.5%

Balance sheet

See full
Cash & equivalents$61.1M-9.4%
Total debt$112.5M-6.1%
Total equity$39.8M-34.6%
Total assets$249.0M-10.7%

Cash flow

See full
Operating cash flow-$41.0M+0.9%
CapEx$46.0K-97.1%
Free cash flow-$41.1M+4.4%

Valuation

See full
Market cap$571.34M-8.7%
Enterprise value$622.67M-8.2%

Profitability

See full
Operating margin-4,498.1%-1,134pp
Net margin-4,342.4%-1,099pp
FCF margin-3,607.4%

Returns & leverage

See full
Return on equity-373.3%-1,281pp
Debt / equity2.8×+0.9×
Current ratio3.1×-0.5×

Where this comes from

Reported directly by Prime Medicine in its filing.

Tagged under the XBRL concept us-gaap:InvestmentIncomeInterest.

The source filing: Prime Medicine’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 8:03 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001628280-26-053883
(in thousands, except share and per share amounts)Three Months Ended June 30, 2026Three Months Ended June 30, 2025Six Months Ended June 30, 2026Six Months Ended June 30, 2025
Total operating expenses44,43954,49295,949108,338
Loss from operations(43,285)(53,377)(93,939)(105,769)
Other income:
Interest income7887431,8091,925
Accretion (amortization) of investments333530793869
Change in fair value of short-term investment — related party(505)(1,561)
Other income, net551810655
Total other income, net1,1767862,7081,288

Item 1. Financial Statements (unaudited)

FAQ

What is Prime Medicine's interest income?
Prime Medicine (PRME) reported interest income of $788K in Q2 2026.
How has Prime Medicine's interest income changed year-over-year?
Prime Medicine's interest income increased by 6.1% year-over-year, from $743K to $788K.
What is the long-term trend for Prime Medicine's interest income?
Over 2 years (2023 to 2025), Prime Medicine's interest income has grown at a 21.5% compound annual growth rate (CAGR), from $2.81M to $4.15M.
What does interest income mean?
Income earned from interest-bearing assets including cash deposits, money market funds, treasury securities, corporate bonds, and customer financing receivables.

Ask your AI about Prime Medicine's interest income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude